Roessler, Martin
Walther, Felix
Eberlein-Gonska, Maria
Scriba, Peter C.
Kuhlen, Ralf
Schmitt, Jochen
Schoffer, Olaf
Funding for this research was provided by:
Technische Universität Dresden
Article History
Received: 20 April 2021
Accepted: 14 December 2021
First Online: 2 January 2022
Declarations
:
: The ethics committee of the TU Dresden approved the study protocol on 24/04/2017 (registered at the Institutional Review Board (IRB): Office for Human Research Protections (OHRP); identification numbers: IRB00001473 and IORG0001076). We obtained consent to participate from the included hospitals before the start of the IMPRESS study. Due to the use of secondary, routine care data, patient consent to participate was not required as confirmed by the ethics committee of the TU Dresden (reference number: EK 186052017). The study adheres to all relevant ethical standards and guidelines, including the Declaration of Helsinki, the Memorandum on the Assurance of Good Scientific Practice of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), the Memorandum III “Methoden für die Versorgungsforschung” of the Deutsches Netzwerk Versorgungsforschung and the guideline “Good practice secondary data analysis” (GPS) of the German Society for Epidemiology (Deutsche Gesellschaft für Epidemiologie, DGEpi) [CitationRef removed].
: Not applicable.
: Peter C. Scriba and Ralf Kuhlen are members of the scientific advisory board of IQM. Maria Eberlein-Gonska serves as an external expert for IQM. The other authors declare that they have no conflict of interest.